ABSTRACT
Chronic migraine is a condition with significant prevalence all around the world and high socioeconomic impact, and its handling has been challenging neurologists. Developments for understanding its mechanisms and associated conditions, as well as that of new therapies, have been quick and important, a fact which has motivated the Latin American and Brazilian Headache Societies to prepare the present consensus. The treatment of chronic migraine should always be preceded by a careful diagnosis review; the detection of possible worsening factors and associated conditions; the stratification of seriousness/impossibility to treat; and monitoring establishment, with a pain diary. The present consensus deals with pharmacological and nonpharmacological forms of treatment to be used in chronic migraine.
Subject(s)
Migraine Disorders/therapy , Chronic Disease , Comorbidity , Humans , Latin America , Migraine Disorders/diagnosis , Risk FactorsABSTRACT
Chronic migraine is a condition with significant prevalence all around the world and high socioeconomic impact, and its handling has been challenging neurologists. Developments for understanding its mechanisms and associated conditions, as well as that of new therapies, have been quick and important, a fact which has motivated the Latin American and Brazilian Headache Societies to prepare the present consensus. The treatment of chronic migraine should always be preceded by a careful diagnosis review; the detection of possible worsening factors and associated conditions; the stratification of seriousness/impossibility to treat; and monitoring establishment, with a pain diary. The present consensus deals with pharmacological and nonpharmacological forms of treatment to be used in chronic migraine.
A migrânea crônica é uma condição com prevalência significativa ao redor do mundo e alto impacto socioeconômico, sendo que seu manuseio tem desafiado os neurologistas. Os avanços na compreensão de seus mecanismos e das condições a ela associadas, bem como nas novas terapêuticas, têm sido rápidos e importantes, fato que motivou as Sociedades Latino-americana e Brasileira de Cefaleia a elaborarem o presente consenso. O tratamento da migrânea crônica deve ser sempre precedido por uma revisão cuidadosa do diagnóstico, pela detecção de possíveis fatores de piora e das condições associadas, pela estratificação de gravidade/impossibilidade de se tratar e pelo monitoramento com um diário da dor. Este consenso apresenta abordagens farmacológicas e não-farmacológicas para tratar a migrânea crônica.
Subject(s)
Humans , Migraine Disorders/therapy , Chronic Disease , Comorbidity , Latin America , Migraine Disorders/diagnosis , Risk FactorsABSTRACT
OBJECTIVE: To verify if the age is a risk factor for secondary headaches, regardless the time interval since the onset of the headache complaint. METHOD: 1131 patients were selected, with the main complaint of headache. The ratio of secondary headaches was evaluated and compared between young and elderly patients in general; between individuals with headache starting before and after 60 years of age; and between young and elderly subjects with headache having started for less than one year. RESULTS: Elderly patients in general and individuals with headache having started after 60 years of age presented a higher ratio of secondary headaches than the young subjects and the ones whose pain started before 60 years of age. Elderly subjects with headache of recent start presented a higher ratio of secondary headaches than young individuals with the same time of pain evolution. CONCLUSION: Age is an independent risk factor for secondary headaches, regardless the time interval since the onset of the complaint.
Subject(s)
Aging/physiology , Headache/etiology , Adolescent , Adult , Age Distribution , Age Factors , Aged , Female , Headache/classification , Headache/diagnosis , Humans , Male , Middle Aged , Prospective Studies , Risk FactorsABSTRACT
OBJETIVO: Verificar se a idade é um fator de risco para cefaléias secundárias independente do tempo de evolução da queixa de dor de cabeça. MÉTODO: Foram selecionados 1131 pacientes com queixa principal de cefaléia. A proporção de cefaléias secundárias foi avaliada e comparada entre pacientes jovens e idosos em geral; entre indivíduos com cefaléia de início antes e após os 60 anos; e entre jovens e idosos com cefaléia de início há menos de um ano. RESULTADOS: Os idosos em geral e os indivíduos com cefaléia de início após os 60 anos apresentaram maior proporção de cefaléias secundárias que os jovens e aqueles com início da dor antes dos 60 anos. Idosos com cefaléia de início recente apresentaram proporção maior de cefaléias secundárias do que os jovens com mesmo tempo de evolução da dor. CONCLUSAO: A idade é um fator de risco independente do tempo de evolução para cefaléias secundárias.
